can you have surgery while on tirzepatide Surgery: Safe Pause, Smart Recovery Tirzepatide and other weight-loss medications

GLP-1 administration induces visceral illness in both rodents (Seeley et al., 2000) and humans (Madsbad et al., 2008)

The 20 Minuten article last week referenced their own articles, which gives a timelineExternal link of the influencers fuelling demand for weight-loss injections

Low energy availability from under-eating is a more common cause of performance decline on these medications than most people realize

Common side effects (nausea, vomiting) typically diminish after several weeks, and most patients report good tolerability beyond the initial adjustment period

These medications have an important role to play in patients with chronic kidney disease [CKD], with or without diabetes, as well as those with cardiovascular disease, he said